D360™ will permit chemical structure and related biological
property data to be shared between global sites
Boehringer Ingelheim plans to install the global data mining tool at three of its sites, located in
“In addition to integrating data for easy access, D360 empowers researchers to query and analyze their data without support from the IT team,” said
Certara is dedicated to improving human health by delivering a broad spectrum of software products and consulting services, spanning molecular discovery to clinical development, with special focus on supporting translational approaches to drug development. A leading provider of model-based drug development tools, Certara was formed by the acquisition and integration of industry leaders Tripos®, Simcyp™, and Pharsight® Corporation. Each Certara family brand focuses on a key phase within the drug discovery and development process; combined, they offer a unique set of scientific modeling, analysis, and simulation capabilities that can enable the cross-disciplinary approaches necessary for translational science initiatives. For more information, visit www.certara.com.